Starting Positions News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Virios Therapeutics, Inc. (NASDAQ: VIRI), a biotechnology company focused on advancing groundbreaking antiviral treatments for chronic conditions like fibromyalgia and Long-COVID, has experienced significant momentum over the past six months. At its peak, the company's stock surged by over 600%. While recent market fluctuations have caused a dip from these record highs, Virios is once

PHOTO: NASA After years of hearing more vendor sales pitches than is healthy for me, I’m convinced most pitches fall into two "why" categories. The first "why" is a pitch so abstract and high-level that it sounds like the technology equivalent of achieving world peace, with nary a mention of the "how" to actually pursue this nirvana. The second "why" pitch focuses on the technology itself — replete with elaborate technology stack diagrams — with scarcely a mention of the actual business benefits that might be tied to the technology. Also missing is any substantial discussion...